Skip to main content

#161883

U2OS PBRM1 KO2

Cat. #161883

U2OS PBRM1 KO2

Cat. #: 161883

Availability: 8-10 weeks

Organism: Human

Tissue: bone

Model: Genetically modified

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jessica Downs, Hugang Freng, Karen Lane

Institute: The Institute of Cancer Research

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: U2OS PBRM1 KO2
  • Research fields: Cancer
  • Parental cell: U2OS
  • Clone: 2
  • Organism: Human
  • Gender: Female
  • Tissue: bone
  • Morphology: Epithelial-like
  • Growth properties: Adherent
  • Model: Genetically modified
  • Model description: PBRM1 knockout
  • Crispr: Yes
  • Conditional: No
  • Products or characteristics of interest: Gene loss-of-function, chromatin-remodelling, DNA damage, cell cycle response, regulation of t-cell-mediated cell killing.
  • Description: HEK293TN cell line knockout for ARID2 knockout (clone 21, also called A21). Note this clone has some residual PBRM1 expression.
  • Application: Chromatin remodelling biology studies
  • Biosafety level: 1
  • Cellosaurus id: CVCL_0042

Applications

  • Application: Chromatin remodelling biology studies

Handling

  • Format: Frozen
  • Growth medium: McCoys 5A =10S + 1% Penicillin/Streptomycin
  • Temperature: 37C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Cultured in antibiotics: 1% Penicillin/Streptomycin
  • Str profiling: See Cellosaurus profile of parental cell line

References

  • Unpublished

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.